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The World Health Organization acknowledges tuberculosis as a global threat.
Tuberculosis infection is one of the top 10 causes of death worldwide.
Nanotechnology and microbiology researchers are looking for new and safe nano
drugs for eliminating Mycobacterium tuberculosis, the causative agent of
tuberculosis. In this study, AgZnO nano-crystals (AgZnONCs) is synthesized via
the decomposition of the precursor of oxalate method. Characterization of
AgZnONCs were evaluated. Next, various concentrations of AgZnONCs, as well
AgZnONCs+Rifampicin, were prepared. TheMTT assay was employed to study the
viability of human macrophage cell lines (THP-1) exposed to AgZnONCs. The
bactericidal effects of AgZnONCs and AgZnONCs+Rifampicin were studied by
Minimum Bactericidal Concentration (MBC) test. Subsequently, THP-1 were
infected by H37Rv strain ofM. tuberculosis (H37RvMtb). Also, bactericidal effects of
AgZnONCs and AgZnONCs+Rifampicin were compared with ex-vivo conditions.
The MBC of AgZnONCs and AgZnONCs+Rifampicin were ratios of 1:4 and 1:32
respectively (p-value <0.05). Also, more than 50% and 80% of THP-1 were alive in
ratios of 1:4 and 1:32 in the presence of AgZnONCs, respectively. All phagocytic
H37RvMtb were killed in the presence of AgZnONCs+Rifampicin (p-value <0.05),
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while AgZnONCs were not able to kill all the H37RvMtb (p-value >0.05). This study
showed that, AgZnONCs+Rifampicin has the most anti-tubercular behavior with
respect to the macrophages.
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1 | INTRODUCTION
According to the last World Health Organization reports, it is
estimated that around 5.4 million male, 3.2 million female,
and about 1million children are suffering from tuberculosis in
the world which, about 1.5 million people have lost their lives
in 2014 [1]. About 3.5% of people which recently tuberculosis
(TB) were diagnosed and about 20.5% of patients who were
previously treated, had multidrug resistant tuberculosis
(MDR-TB) in which half of those patients did not complete
their prescribed drug regimen. The problem of tuberculosis
patients is not only the Mycobacterium tuberculosis (Mtb)
resistance to rifampicin or isoniazid but also to other anti-TB
drugs.Mtb penetrates by enters to the respiratory tract through
ultrafine infectious particles into alveoli, where by alveolar
macrophages are phagocytized. Mtb is able to prevent its
connectionwith phagosomes or lysosomes. The phagocytized
bacteria are able to escape from nitrogen-containing active
agents, oxidase and catalase agents [2]. Due to related factors
to Mycobacterial infection, tuberculosis treatment presented
issues during chemotherapy. Due to the chemotherapy, the
body's defense mechanism is inefficient, and the patient is
considered to be immunocompromized. Although many
people are affected with TB in a latent state, only a small
percentage of people actually develop active, symptomatic
pulmonary TB. In addition, pathological anatomy of lesions
with high leukocytes infiltration and central calcification,
drugs penetration to the appropriate concentrations becomes
too difficult and antibiotics usually do not have access to the
Mtb. Most anti-TB drugs have bacteriostatic activity and
requires a lengthy treatment. Other difficulties in TB
treatment are the emergence of resistance in microorganisms,
and finally toxic side effects of drugs hinders their use or
forces the prescription of low-doses. Using the combination
therapy will prevent the emergence of resistance [2,3]. Today,
nanotechnology is used widely in various aspects in medical
sciences and basic sciences. Researchers believed that
colloidal nanoparticles and agglomerates are able to limit
the growth of bacteria and even destroy their cellular
structure [4]. Many studies have been conducted on the
antibacterial effects of Ag and ZnO nanoparticles [5–9].
Silver has always been the most promising candidate to be
investigated for its inhibitory and antibacterial properties
since ancient times [10]. In fact, Ag ions and Ag-based
compounds are highly toxic to microorganisms, showing
biocidal effects on pathogenic bacteria [11]. On the other
hand, using just silver nanoparticles may be ineffective
against some bacteria, because the antibacterial properties of
silver nanoparticles are weak. Based on previous studies,
synergistic effects of silver and zinc oxide nanoparticles
(AgZnONPs) have been proven effective on various bacte-
ria [12–14]. Zinc oxides has been recognized as antibacterial
material in recent years. For several decades, they have been
used in medicine as mild topical astringents, and antibacterial
agents against eczema, slight excoriations, in wounds, and for
hemorrhoids [11]. Zinc oxide has been approved as a safe
material by the U.S Food and Drug Administration (FDA,
2011) and its antibacterial activity has been long known [11].
Therefore, silver and zinc oxide nano-crystals (NCs) offer
potential applications in antimicrobial coatings and for
coating surgical instruments to prevent nosocomial infec-
tions [10]. Scientists reported antimicrobial activity of silver
nanoparticles in combination with zinc oxide nanopar-
ticles [11]. Rifampicin, a semisynthetic antibiotic for
Mycobacterium and methicillin-resistant Staphylococcus
aureus infection treatment [15]. Recently, researchers are
interested to investigating about synergism and antibacterial
effects of metal oxide nano-crystals (NCs) containing
currency antibiotics such as rifampicin [15].
In this study, we explored the toxicity of silver/zinc oxide
nano-crystals (AgZnONCs) on the human macrophages
(THP-1) cell lines and investigated synergistic effects of
mixed AgZnONCs with rifampicin, before (in vivo) and after
(ex vivo) phagocytosis against H37RvMtb.
2 | MATERIALS AND METHODS
2.1 | Characterization of NCs, chemicals,
H37RvMtb strains, growth media, and THP-1
cell lines
Experimental studies were performed February 1, 2016 till
September 14, 2016 at Institute of Immunology and
Infectious Diseases (IIID), Anti-microbial Resistance Re-
search Center, Iran University of Medical Sciences (IUMS).
The AgZnONCs were synthesized and its properties were
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investigated [16]. Experiences of dependent on the crystal-
linity of the NPs were carried out using X-ray diffract meter
set (XRD, Bruker D8-Advance Diffract meter using Cu Kα
radiation). Fourier transform infrared (FT-IR) spectra were
recorded on a Bruker spectrophotometer in KBr pellets.
Surface morphology of product was characterized by using a
scanning electronic microscopy (SEM, Cam Scan MV2300)
with an accelerating voltage of 30 KV. Also, different
dilutions of NCs were prepared (Tables 4 and 5). Next, the
concentration of NCs was determined at each dilution [10].
H37RvMtb (ATCC 27294) was provided from Razi Vaccine
and Serum Research Institute. THP-1 cell line was obtained
from cell bank of Pasteur Institute of Iran and next, was
cultured in RPMI 1640 medium (Thermo Fisher Scientific,
USA), FBS 10%, penicillin 100 Uml−1 and 100 mgml−1 of
streptomycin (Sigma–Aldrich, USA) and then incubated at
5% CO2 at 37 °C. When cell density reached to 80%, THP-1
cells (about 104 cell/well) were cultured in each plate.
2.2 | Preparation of H37RvMtb and different
dilutions of NCs
Two colonies of H37RvMtb were removed from Lowenstein
Jensen (LJ) agar medium (Fisher Bio Reagents, USA) and
were transferred into gated test tube containing 5 ml of sterile
saline and was stirred for 5–10 min with a shaker device. The
opacity in the test tube containing the intended bacteria was
compared with opacity in a 0.5 McFarland test tube,
macroscopically. In order preparation of 10−1, 10−2, 10−3,
and 10−4 dilutions of H37RvMtb, four gated test tube
containing 5 ml of sterile saline were prepared and serial
dilutions were done. Also, to prepare AgZnONCs+Rifampi-
cin, 0.16384 g of AgZnONCs and 0.0008 g of rifampicin were
mixed into the 20 ml of LJ agar medium.
2.3 | Anti-tubercular activity of AgZnONCs
and AgZnONCs+rifampicin
To investigation about anti-tubercular activity of NCs,
Minimum Bactericidal Concentration (MBC) test was used.
About 0.32768 g of AgZnONCs was poured separately into
the sterile tube, containing 20 ml of melted LJ agar medium as
a negative control and after shaking, it was ultra-sonicated for
10 min in room temperature. After pipetting, about 10 ml of
melted LJ agar containing AgZnONCs was added to the
subsequent tube containing 10 ml of melted LJ agar medium.
Serial dilution was done. Last tube was treated as a positive
control. To MBC tests, about 10−2 (75 × 106 CFUml−1) and
10−4 (18.7 × 104 CFUml−1) dilutions of H37RvMtb were
prepared and likewise, about 100 ml ofH37RvMtbwere added
to each tubes and kept in an incubator at 37 °C for 28 days.
Then, tubes were removed from the incubator and the colony
forming units (CFU) were counted accurately for any dilution
(Table 1). Meanwhile, MBC test of AgZnONCs+Rifampicin
against H37RvMtb was performed in accordance with the
above procedure. Also, MBC tests were performed three
times.
2.4 | MTT assay
The cytotoxicity effects of AgZnONCs on THP-1 cells in 24 h
were determined byMTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5-
diphenyltetrazolium bromide) assay. The cells (104cell=well)
were seeded in RPMI-1640 (Thermo Fisher Scientific),
medium (200 ml per well) in 96-well plates and incubated at
37 °C in 5% CO2 for 24 h, to induce cell adherence. Next,
serial dilution was done. Separately, THP-1 cells were treated
with 100 μl of freshly prepared AgZnONPs and further
incubated at 37 °C in 5% CO2 for 48 h. To the MTT assay,
20 μl of MTT solution (5 mgml−1 in incomplete medium)
was added and incubated for 5 h. Next, 100 μl DMSO was
added and the plates put on a shaker for 5 min. The maximum
absorbance was measured at 560 nm using a microtiter plate
reader (Biotech, USA) [17]. Cell viability in control cells was
assumed to be 100%. The percentage of cells viability were
calculated by using the following equation:
%THP‐1 cells viability ¼Optical Density ODð Þ of test
OD of controls
 100
2.5 | The infectious THP-1 cell lines by
H37RvMtb and treated with NCs
The infectious THP-1 cell lines with H37RvMtb was
performed under five steps. In first step, RPMI-C medium
(“RPMI-Complete”) was prepared (Table 2). A day before
infection, 50 nM of phorbol myristate acetate (PMA)
(SIGMA, USA) were added to THP-1 cell lines in RPMI-C
medium. Next, RPMI-I medium (“RPMI-infection”) was
ready (Table 3). One day before infection, about 10−2 and
10−4 McFarland of H37RvMtb were prepared. Also, about
100 μl of THP-1 cells (1 × 105 cells/well) were placed into 96-
well micro-plate. Then, macrophages were washed with PBS
and then 100 ml of RPMI-I medium culture were added and
cells were incubated. After that, three ml of suspension of
different dilution of H37RvMtb were centrifuged for ten
minutes at 2400 rpm, and three ml of fresh 7H9-C medium
culture were added. Next step, H37RvMtb and THP-1 cell
lines were mixed in RPMI-I medium; afterwards, infected
macrophages were incubated at 37 °C for 3 h under 0.5%CO2.
Macrophages were washed twice with PBS at 37 °C to
remove extracellular bacteria. Then, RPMI-C containing
20 µg ml−1 gentamicin were added to medium. Fourth step,
different ratios of AgZnONCs and AgZnONCs+Rifampicin
were used to treatment of infected macrophages. Afterwards,
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they were incubated at 37 °C for 24 h under 0.5% CO2. Next,
macrophages were lyzed by 0.05% SDS and cultured in LJ
agar medium. About 25 μl of lyzed cells were transferred to
the new micro-plate containing 225 μl of MGIT broth
medium (Sigma), until the serial dilution was done. Next
step, 100 μl of the selected dilution were cultured in LJ agar
medium.
2.6 | Preparation to TEM and SEM
For preparing of transmission electron microscopy (TEM)
(Philips CM30, USA) image of the infectious THP-1 and
NCs, it was fixed by glutaraldehyde 2.5% (Sigma–Aldrich).
Then, it was washed by Sodium cacodylate trihydrate
(Sigma–Aldrich) buffer in two steps, one step for 15 min
and another for 30 min. After washing, the suspension was
fixed by osmium tetroxide 1% (Sigma–Aldrich) immediately.
Next step, dehydration was performed with ethanol 50%,
70%, 90%, and 100%, respectively. The contents of the cell
were immersed in pure propylene oxide (Sigma–Aldrich) and
various degrees of propylene oxide and resin (Sigma–
Aldrich), and then were placed in pure resin. After that, the
sample was placed in oven at 60 °C for 24 h. Finally, the
obtained samples were cut using ultra-microtome (Reichert-
Leica, USA) in very thin pieces and painted by uranyl acetate
2% (Sigma–Aldrich) and Lead (II) citrate tribasic trihydrate
2% (Sigma–Aldrich) and were placed on the special grades by
TEM. To identification and analysis of AgZnONCs, scanning
electron microscope (SEM) (Hitachi S4160, Japan) was used.
NCs were diluted in distilled water and poured on copper
Stub. Then, NCs were coated by a thin layer of gold under
vacuum conditions to be conductive. Surface covered with
gold was scanned and photography was performed by
accelerating voltage 10 kV.
2.7 | Statistical analysis
In this study, statistical data analysis was performed by
SPSS 16 software. Significant difference between the
different concentrations of AgZnONCs on H37RvMtb
were studied by analysis of variance one-way ANOVA
and the comparison of data in alpha level of 0.05 and
confidence 95%. The diagrams were drawn with Microsoft
Excel (version of 2017). Experiments were performed three
times.
3 | RESULTS
3.1 | Characterization of AgZnONCs
Characterizations of AgZnONCs were consistent with
previous studies of Jafari et al. The FTIR spectrum showed
that the shoulder at 1458.22 cm−1 and 1628.14 cm−1 are
present in the spectrum evidence of covalent bond between
nitrogen and oxygen tremble and the closely spaced bands
625.36 cm−1 are presents in the spectrum evidence of
AgZnONCs tensional tremble, respectively (Fig. 1). Also,
the broad band at 3426.47 cm−1 was allocated of hydration
water [18]. The XRD patterns of AgZnONCs (Fig. 2) was
associated with standard information of International Centre
of DiffractionData (ICDD). The average crystallite size of the
nano-crystals were designed using the Debye-Scherer
Equation. The average crystallite size of the AgZnONCs
were about 12 nm. Estimated size of nano-crystals, as well
clustering and spherical morphology was showed via SEM
image (Fig. 3).
3.2 | Anti-tubercular activity of AgZnONCs
and AgZnONCs+rifampicin
Consistent to the results (Tables 4 and 5), none of the dilutions
of AgZnONCs were not able to kill of 10−1 (15 × 107
CFUml−1) H37RvMtb. Statistical data also did not show any
significant difference between control group and other
dilutions (p-value >0.05). However, different behavior of
TABLE 1 The resistance ratio of the number of colonies observed in
LJ agar medium
Symbol Colony count of Mtb
+1 150–300
+2 300–500
+3 ∼500
+4 500≤
TABLE 2 Preparation of RPMI-C medium
RPMI-C mediums
Material Volume Company
RPMI media 450 ml Thermo fisher Scientific
HEPES 1% (or 5 ml) 1 mM Sigma–Aldrich
2-Mercaptoethanol 0.1% (or 500 µl) Sigma–Aldrich
Gentamicin 20 µg ml−1 Sigma–Aldrich
TABLE 3 Preparation of RPMI-I medium
RPMI-I medium
Material Volume Company
RPMI media 450 ml Thermo fisher
Scientific
HEPES 1% (or 5 ml)
1 mM
Sigma–Aldrich
2-Mercaptoethanol 0.1% (or
500 µl)
Sigma–Aldrich
Non-heat-inactivated
human serum
10% Gemini Bio-
products
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H37RvMtb in dilution of 10
−2 (75 × 106 CFUml−1), 10−3
(37.5 × 105 CFUml−1), and 10−4 (18.75 × 104 CFUml−1)
were observed (Table 4). Statistical analysis showed
significant differences between the CFU of H37RvMtb at
dilution of 4096 μg ml−1 and control group in all dilutions (p-
value <0.05) (Fig. 4). Results showed that, mixed AgZ-
nONCs+Rifampicin could kill about 10−1 (15 × 107
CFUml−1) H37RvMtb in dilution of 1024:2.5 µg ml
−1.
Also, it could kill about 10−2 (75 × 106 CFUml−1), 10−3
(37.5 × 105 CFUml−1), and 10−4 (18.7 × 104 CFUml−1)
H37RvMtb at ratio of 1:32 (MBC= 512:1.25 µg ml
−1). In
comparison with AgZnONCs, the MBC of AgZnONCs
+Rifampicin in dilution of 10−2, 10−3, and 10−4 was reduced
until eight times (Table 5). Statistical analysis presented
significant differences in dilution of 1:32, 1:16 (p-value
<0.05) (Fig. 5).
3.3 | MTT assay
According to MTT assay (Fig. 6), 4096 μg ml−1 of
AgZnONPs did not have any cytotoxicity effect on THP-1
cell line. In fact, the number of viable THP-1 cells was
increased with reducing of the concentration of AgZnONPs.
Also, dilutions of 512 μg ml−1 and 256 μg ml−1 the viability
percent of THP-1 cells reached to more than 80%, compared
with the control group (Fig. 6).
3.4 | The infectious THP-1 cell lines by
H37RvMtb and treated with AgZnONCs and
AgZnONCs+rifampicin
The results of culturing infectious THP-1 cells with 10−2, and
10−4 McFarland of H37RvMtb and treated with different
dilution of AgZnONCs, compared to the control group
FIGURE 1 FT-IR spectra of AgZnONCs. The spaced band 625.36 cm−1 is presents in the spectrum evidence of AgZnONCs tensional
tremble
FIGURE 2 XRD pattern of AgZnONCs displays a typical specrtum of the nano crystalline Ag and ZnO prepared with oxalate decomposition
route. These results reveal that although the ZnO peaks are more evident, two phases (Ag and ZnO) co-exist
JAFARI ET AL. | 45
showed that 8192 μg ml−1 of AgZnONCs able to kill of 10−2
McFarland of H37RvMtb into the THP-1 cells, so weakly.
However, it has been notice that it cannot be active not only by
4096 μg ml−1, but also in other dilutions. In low concentration
of bacteria, no colonies were observed in the 8192 μg ml−1.
However, it had a weak growth. Also, it was found that the
CFU increases after another in 2048 μg ml−1 to 32 μg ml−1
dilutions, gradually (Fig. 7).
By the way, it has been demonstrated that AgZnONCs
+Rifampicin is able to kill 10−2 H37RvMtb into the THP-1
cell lines in dilution of 8192:20 μgml−1, 4096:10 μgml−1,
2048:5 μgml−1, completely and in dilution of 1024:2.5 μgml−1,
defectively. Meanwhile, it was found that further dilutions do
not have any anti bactericidal effects on phagocytic bacteria.
While, anti-tubercular behavior of AgZnONCs+Rifampicin
was intensified inpresent of 18.75 × 104CFUml−1 ofMtb. So, it
can be strongly believe that 8192:20 μgml−1 till
512:1.25 μgml−1 dilution of AgZnONCs+Rifampicin able to
completely kill all of bacteria into the macrophages. Also, the
weak growth of H37RvMtb colonies was shown in
256:0.625 μgml−1 (Fig. 8).
4 | DISCUSSION
TB treatment has become a major problem due to some
factors related to bacterial infection. First, the body's defense
mechanism in tuberculosis patients are incompetent. For this
reason, pulmonary tuberculosis occurs only in a few number
of people that infected with tuberculosis. In addition,
pathological anatomy of lesions with high leukocyte
infiltration and their central calcification that make difficult
the penetration of drug at appropriate concentrations. Also,
M. tuberculosis has some unfavorable characteristics. For
instance, their metabolism is slow and some of them take
place within cells and may remain a long time in calcified and
fibrous lesions. These factors along with the fact that most
anti-TB drugs only have bacteriostatic activity prolong the
treatment of this disease. Other problems of Tb treatment are
TABLE 4 The MBC outcomes of AgZnONCs were compared to the different dilutions of H37RvMtb (*p-value <0.05 are representative of
significant values and **p-value >0.05 are indicative of non-significant values)
Ratios and concentration (ppm) of AgZnONCs
Dilution of H37Rv (CFUml−1) 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 Control
8192 4096 2048 1024 512 256 128 64 32
10−1 (15 × 107) +2** +3** +3** +3** +3** +3** +3** +3** +3** +4
10−2 (75 × 106) 0* MBC* +1** +2** +2** +2** +2** +3** +3** +4
10−3 (37.5 × 105) 0* MBC* +1** +2** +2** +2** +3** +3** +3** +4
10−4 (18.75 × 104) 0* MBC* +1** +1** +1** +2** +3** +3** +3** +4
TABLE 5 The MBC results of AgZnONCs+Rifampicin were compared to the different dilutions of H37RvMtb (*p-value <0.05 are representative
of significant values and **p-value >0.05 are indicative of non-significant values)
Ratios and concentration (ppm) of AgZnONCs+rifampicin
Dilution of H37Rv
(CFUml−1)
1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 Control
8192:20 4096:10 2048:5 1024:2.5 512:1.25 256:0.625 128:0.312 64:0.156 32:0.078
10−1 (15 × 107) 0* 0* 0* MBC* +1** +1** +3** +3** +3** +4
10−2 (75 × 106) 0* 0* 0* 0* MBC* +1** +2** +3** +3** +4
10−3 (37.5 × 105) 0* 0* 0* 0* MBC* +1** +2** +3** +3** +4
10−4 (18.75 × 104) 0* 0* 0* 0* MBC* +1** +2** +3** +3** +4
FIGURE 3 SEM image of AgZnONCs showed that metallic
particles were exactly in the shape of spherical and cluster
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the emergence of antibiotic resistant M. tuberculosis, and
cytotoxic effects of new antibiotics [19]. According to the
previous study, silver (AgNCs) and zinc oxide nano-crystals
(ZnONCs) have antibacterial effects on wide ranges of
bacteria, also have synergistic effects on each other [16,20].
Recently, it was found that ZnO colloidal nanoparticles are
not toxic against human lungs normal fibroblasts (MRC-5)
and human macrophage (THP-1) cell lines [12]. Despite of
FIGURE 4 Anti bactericidal effects of different ratios of AgZnONCs in present of 1:10 (10−1), 1:100 (10−2), 1:1000 (10−3), and
1:10,000 (10−4) McFarland of H37RvMtb
FIGURE 5 Anti bactericidal effects of different ratios of AgZnONCs+rifampicin in present of 1:10 (10−1), 1:100 (10−2), 1:1000 (10−3), and
1:10,000 (10−4) McFarland of H37RvMtb
FIGURE 6 Viability of THP-1 cell lines in exposure with different dilution of AgZnONCs
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this fact that ZnONCs revealed very strong activity against
gram positive and gram negative bacteria.
According to Jafari et al. [21], mixed silver and zinc oxide
nano colloidal particles had anti-tubercular impact on
H37RvMtb. They also fined that 40 ppm of rifampicin could
not be able to eliminate 75 × 104 CFUml−1 H37RvMtb after
phagocytized by THP-1 cell lines. According to current study,
combination of 1024 μg ml−1 of AgZnONCs with 2.5 ppm of
rifampicin was able to eliminate 75 × 104 CFUml−1 H37Rv
strain of MTB after phagocytized. While, AgZnONCs could
not be able kill all bacteria into the THP-1 cells. Sarkar
et al. [22] investigated on cytotoxicity of silver colloidal NPs
in various aspects with THP-1 as well as the innate immune
response in the face of H37RvMtb. The results of this study
showed that the viability of THP-1 cells reduced in the present
of AgNCs. López-Heras et al. [23] had talked about the
antibacterial properties of AgNCs and suggested that AgNCs
can be used to inhibit the growth of bacteria in respiratory
infections. In this study, they investigated antibacterial
properties of AgNCs that were uptake the Mtb infected
withmacrophages. Similar to current research, they infectious
THP-1 cells with Mtb and investigated various cellular
structures and their changes [23]. Recently, using of
conjugated nano-medicine in order treatment of TB has
FIGURE 7 Comparison between antibacterial effects of AgZnONCs and AgZnONCs+rifampicin against 75 × 106 CFUml−1 (1:00
McFarland) of H37RvMtb infected by THP-1 in the presence of different dilution of AgZnONCs
FIGURE 8 Comparison between antibacterial effects of AgZnONCs and AgZnONCs+rifampicin against 18.5 × 106 CFUml−1 (1:10,000
McFarland) of H37RvMtb infected by THP-1 in the presence of different dilution of AgZnONCs
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been changed to the title which is interesting for researchers.
Leidinger et al. [24] considered the antibacterial effects of
isoniazid-filled Fe2O3 as a nano-medicine in the treatment of
TB against phagocytic Mtb. Their results indicated that
isoniazid-filled Fe2O3 had a very strong antibacterial activity
against Mtb in the in vivo and ex vivo. They introduced
isoniazid-filled Fe2O3 as “Trojan horses.” Mohanety
et al. [25] investigated the antibacterial peptides and the
AgNPs against a variety strains of Mtb. AgNPs were
synthesized with a biological method via bacteria, fungi,
and plants and were combined with various antibacterial
peptides. Hala achieved some results on the antibacterial
effects of Au Nano-rods (AuNRs) and AuNRs+Rifampin
against Mtb and phagocytic Mtb with macrophage cell
lines [26]. According current results, the AgZnONCs able to
destroy all the Mtb in in-vitro condition. In fact, after
phagositosis both of AuNRs and AgZnONCs had penetrated
into the macrophage. Interestingly, they figured out that
AuNRs+Rifampin able to remove all of bacteria into
macrophage. But AgZnONCs was able to kill about 10−2
(75 × 106 CFUml−1)Mtb into macrophage at dilution of 1:16
(1024 µg ml−1), without the involvement of the rifampicin. It
was confirmed the presents of nano-crystals into the
macrophage via TEM images (Fig. 9). Also, TEM image
showed Mtb into the cytosol of macrophage (Fig. 10) and
the MTT assay showed that more than 50% of the cells were
alive in concentration of 4096 µg ml−1. However, there were
no reliable and the concentration seemed somehow toxic.
Conversely, it was demonstrated synergistic effects between
the AgZnONCs and the rifampicin. In fact, it was indicated
that AgZnONCs+Rifampicin is able to kill about 10−4
bacteria at dilution of 1:32. The fact is that, more than 80% of
macrophage cells which were exposed to AgZnONCs were
alive and it was a good news. TEM image showed that
AgZnONCs were not able to kill the bacteria in ex-vivo
condition, completely (Fig. 10). Also, Figs. 11 and 12 were
designed as a schematic illustration of anti-tubercular impact
of AgZnONCs against H37RvMtb. This study also showed
that antibacterial properties of AgNPs and ZnONPs could be
increase by mixing nanoparticles with antibiotics such as
rifampicin, which has more for permeating into lung tissue
fibrin layer. Studies have shown that some magnetic NPs are
able to induce capable macrophage for phagocytosis.
However, it can be pointed as spark for future researches
for synthesis of mixed metal oxide and magnetic NPs with
FIGURE 9 TEM image of the THP-1 cell treated with
AgZnONCs with magnification of 750 nm. Clearly, it is obvious
that NCs have penetrated into the macrophage cell line
FIGURE 10 TEM image show that some phagocytosis
H37RvMtb and nano-crystals are afloat into the THP-1 cell cytosol
FIGURE 11 Schematic illustration of anti-bacterial effects of AgZnONCs against H37RvMtb (in vitro) and viability of THP-1 cells as a host
cell of H37RvMtb in present of different dilution of AgZnONCs
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antibacterial as well macrophage inducer properties against
inner cellular bacteria especially Mtb.
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